Cannabis Clinical Trials Decriminalization State Laws 
NORML
JANUARY 4, 2019
Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Click here to email your member of Congress and urge them to join the Cannabis Caucus.
NORML
JANUARY 18, 2019
Representative Lou Correa (D-CA) this week introduced HR 493: The Sensible Enforcement Of Cannabis Act, which would codify the protections that were outlined in the now-rescinded Cole Memo. House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 7, 2022
This includes a range of substances, including LSD, psilocybin, cannabis, and heroin. Some exceptions have been made to allow the use of certain psychedelics in religious ceremonies, and some states and municipalities have deprioritized enforcement of laws prohibiting possession of plant and fungi-derived substances (see below).
Canna Law Blog
MARCH 4, 2020
Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).
Cannabis Law Report
AUGUST 30, 2019
Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. The SAFE Banking Act (H.R.
Canna Law Blog
MARCH 4, 2020
Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).
The Blunt Truth
AUGUST 13, 2019
Other CBD products, however, are still subject to various state law regulations as well as the U.S. 331(ll)), the FDA prohibits the sale of products containing an ingredient that has been treated as a drug or involved in clinical trials, without prior FDA approval. Under section 331(ll) of the FD&C Act (21 U.S.C.
Expert insights. Personalized for you.
124 
Let's personalize your content